Table 1 Characteristics of the participants.
Subgroup | No | |
|---|---|---|
Gender | Female | 10 |
Male | 7 | |
Age | 18–29 | 1 |
30–39 | 2 | |
40–49 | 2 | |
50–59 | 5 | |
60–69 | 4 | |
70–75 | 3 | |
Highest education | Highschool or less | 3 |
Up to 2 years of post-secondary level | 8 | |
>2 years of post-secondary level | 6 | |
Cancer history | Yes | 13 |
No | 4 | |
Genetic testing | Screening | 13 |
Predictive testing | 4 | |
Family diagnosis | Familial breast cancer (Negative screening of breast cancer gene panel, but surveillance with yearly mammograms offered to ARRs) | 6 |
Familial colorectal cancer (Negative screening of colorectal cancer gene panel, but surveillance with colonoscopy every 5th year offered to ARRs) | 3 | |
Lynch syndrome (Predictive testing of pathogenic variant in MLH1, MSH2, MSH6 or PMS2 offered to ARRs) | 3 | |
Hereditary breast and ovarian cancer (Predictive testing of pathogenic variant in BRCA1, BRCA2, or PALB2 offered to ARRs) | 5 | |
Study allocation | Control | 7 |
Intervention | 10 |
